Home‎ > ‎About Us‎ > ‎

Dr. Robert Lodder

Robert A. Lodder received his B.S. degree cum laude in Natural Science from Xavier University (Cincinnati, Ohio). After deciding to pursue a career in chemistry he worked under Professor Richard T. O'Neill at Xavier, and received his M.S. in Chemistry. He received his Ph.D. in Analytical Chemistry after working with Professor Gary M. Hieftje at Indiana University, and is currently Professor of Pharmaceutical Sciences at the College of Pharmacy, University of Kentucky Medical Center.

Dr. Lodder holds joint appointments as a professor in the Department of Electrical and Computer Engineering, and the Division of Analytical Chemistry of the Department of Chemistry at Kentucky.

Dr. Lodder is a first-prize winner in the international IBM Supercomputing Competition, as well as a winner of a National Science Foundation Young Investigator Award, the American Society of Agricultural Engineers Paper Award, a Buchi NIR Award, the Tomas Hirschfeld Award in Near-IR Spectroscopy (PittCon), a Research and Development 100 Award, and the Orville N. Green Award (SETICon).

If you don't see an animation above, click here to see the visible image turn into infrared (44K MPEG version)

Dr. Lodder has conducted mathematical studies aimed at solving the "false-sample" problem in thought-like operations on parallel processors. The parallel processing concepts have been extended to analytical instrumentation itself in the form of systems for hyperspectral integrated computational imaging (HICI) and the development of magnetohydrodynamic acoustic-resonance near-infrared spectrometry (MAReNIR). He has founded two companies with venture capital based on these new technologies.

The results of these studies have been applied to a number of different analytical problems, including near-infrared imaging, pharmaceutical quality control, and the detection of product tampering in foods and pharmaceuticals. These studies have also led to progress in noninvasive methods for analyzing complex biological samples. The new imaging technology is now being applied to in vivo studies of the role of selected proteins and lipids in atherogenesis, and has been used in three-dimensional imaging of painted historical surfaces under restoration.

Contact Dr. Lodder:
Tel: 18599550845
E-mail: Lodder at uky.edu
Robert Lodder,
Aug 1, 2016, 3:09 PM